Nutrigenomics deals with the study of the nutritional impact of gene expressive and metabolism. The growing popularity of nutritious food is expected to impel growth in the market. Several cancer-based institutions stated that effective diet regulation can decrease the prevalence of cancer. The nutrigenomics market growth is likely to benefit from increasing advances in genomics and molecular biology. Leading nutrigenomics companies in developed and developing countries to offer door to door services, which is expected to accelerate the adoption of nutrigenomics testing during the forecast period.
MARKET SCOPE
The "Global Nutrigenomics Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Nutrigenomics market with detailed market segmentation by products, applications, and geography. The report provides key statistics on the market status of the leading Nutrigenomics market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on products, the global Nutrigenomics market is segmented into Reagents and Kits, Services.
- Based on application, the market is categorised into Obesity, Cardiovascular Diseases, Diabetes, Cancer Research, Others.
MARKET DYNAMICS
Drivers:
- Increase in personalized nutrition and evaluation of food safety.
- Various development in the global market in the field of nutrition and diet.
- Government initiatives supporting nutigenomics
- Increased awareness among the people about daily nutritious diet intake.
Restraints
- Concerns regarding ethical nature of this technology and .
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Nutrigenomics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Nutrigenomics market in these regions.
IMPACT OF COVID-19 ON NUTRIGENOMICS MARKET
The problem of the global pandemic of COVID 19 has disrupted many businesses. Small businesses have shut down or have shown a downfall in their earnings. The COVID 19 is highly infectious and spread through human interaction. During this time it has become the need of an hour to increase the consumption of good nutritious food to gain high immunity to fight this life-taking virus. During the lockdown situation, the nutrigenomics market has shown a downfall in the demand but later on, owing to the situation and increasing awareness among people regarding the importance of a good nutritious diet has marked the heights of the nutrigenomics segment.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Nutrigenomics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Nutrigenomics market in these regions.
IMPACT OF COVID-19 ON NUTRIGENOMICS MARKET
The problem of the global pandemic of COVID 19 has disrupted many businesses. Small businesses have shut down or have shown a downfall in their earnings. The COVID 19 is highly infectious and spread through human interaction. During this time it has become the need of an hour to increase the consumption of good nutritious food to gain high immunity to fight this life-taking virus. During the lockdown situation, the nutrigenomics market has shown a downfall in the demand but later on, owing to the situation and increasing awareness among people regarding the importance of a good nutritious diet has marked the heights of the nutrigenomics segment.
MARKET PLAYERS
The report covers key developments in the Nutrigenomics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Nutrigenomics market are anticipated to lucrative growth opportunities in the future with the rising demand for Nutrigenomics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Nutrigenomics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- WellGen Inc.
- Metagenics, Inc.
- Genomix Nutrition, Inc.
- Nutrigenomix
- NutraGene
- XCODE Life Sciences Pvt. Ltd.
- Cura Integrative Medicine
- GX SCIENCES
- Royal DSM
- BASF SE
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nutrigenomics Market - By Product
1.3.2 Nutrigenomics Market - By Application
1.3.3 Nutrigenomics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NUTRIGENOMICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NUTRIGENOMICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NUTRIGENOMICS MARKET - GLOBAL MARKET ANALYSIS
6.1. NUTRIGENOMICS - GLOBAL MARKET OVERVIEW
6.2. NUTRIGENOMICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. NUTRIGENOMICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. REAGENTS AND KITS
7.3.1. Overview
7.3.2. Reagents and kits Market Forecast and Analysis
7.4. SERVICES
7.4.1. Overview
7.4.2. Services Market Forecast and Analysis
8. NUTRIGENOMICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. OBESITY
8.3.1. Overview
8.3.2. Obesity Market Forecast and Analysis
8.4. CARDIOVASCULAR DISEASES
8.4.1. Overview
8.4.2. Cardiovascular Diseases Market Forecast and Analysis
8.5. DIABETES
8.5.1. Overview
8.5.2. Diabetes Market Forecast and Analysis
8.6. CANCER
8.6.1. Overview
8.6.2. Cancer Market Forecast and Analysis
8.7. OTHER CHRONIC DISEASES
8.7.1. Overview
8.7.2. Other Chronic Diseases Market Forecast and Analysis
9. NUTRIGENOMICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Nutrigenomics Market Overview
9.1.2 North America Nutrigenomics Market Forecasts and Analysis
9.1.3 North America Nutrigenomics Market Forecasts and Analysis - By Product
9.1.4 North America Nutrigenomics Market Forecasts and Analysis - By Application
9.1.5 North America Nutrigenomics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Nutrigenomics Market
9.1.5.1.1 United States Nutrigenomics Market by Product
9.1.5.1.2 United States Nutrigenomics Market by Application
9.1.5.2 Canada Nutrigenomics Market
9.1.5.2.1 Canada Nutrigenomics Market by Product
9.1.5.2.2 Canada Nutrigenomics Market by Application
9.1.5.3 Mexico Nutrigenomics Market
9.1.5.3.1 Mexico Nutrigenomics Market by Product
9.1.5.3.2 Mexico Nutrigenomics Market by Application
9.2. EUROPE
9.2.1 Europe Nutrigenomics Market Overview
9.2.2 Europe Nutrigenomics Market Forecasts and Analysis
9.2.3 Europe Nutrigenomics Market Forecasts and Analysis - By Product
9.2.4 Europe Nutrigenomics Market Forecasts and Analysis - By Application
9.2.5 Europe Nutrigenomics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Nutrigenomics Market
9.2.5.1.1 Germany Nutrigenomics Market by Product
9.2.5.1.2 Germany Nutrigenomics Market by Application
9.2.5.2 France Nutrigenomics Market
9.2.5.2.1 France Nutrigenomics Market by Product
9.2.5.2.2 France Nutrigenomics Market by Application
9.2.5.3 Italy Nutrigenomics Market
9.2.5.3.1 Italy Nutrigenomics Market by Product
9.2.5.3.2 Italy Nutrigenomics Market by Application
9.2.5.4 Spain Nutrigenomics Market
9.2.5.4.1 Spain Nutrigenomics Market by Product
9.2.5.4.2 Spain Nutrigenomics Market by Application
9.2.5.5 United Kingdom Nutrigenomics Market
9.2.5.5.1 United Kingdom Nutrigenomics Market by Product
9.2.5.5.2 United Kingdom Nutrigenomics Market by Application
9.2.5.6 Rest of Europe Nutrigenomics Market
9.2.5.6.1 Rest of Europe Nutrigenomics Market by Product
9.2.5.6.2 Rest of Europe Nutrigenomics Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Nutrigenomics Market Overview
9.3.2 Asia-Pacific Nutrigenomics Market Forecasts and Analysis
9.3.3 Asia-Pacific Nutrigenomics Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Nutrigenomics Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Nutrigenomics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Nutrigenomics Market
9.3.5.1.1 Australia Nutrigenomics Market by Product
9.3.5.1.2 Australia Nutrigenomics Market by Application
9.3.5.2 China Nutrigenomics Market
9.3.5.2.1 China Nutrigenomics Market by Product
9.3.5.2.2 China Nutrigenomics Market by Application
9.3.5.3 India Nutrigenomics Market
9.3.5.3.1 India Nutrigenomics Market by Product
9.3.5.3.2 India Nutrigenomics Market by Application
9.3.5.4 Japan Nutrigenomics Market
9.3.5.4.1 Japan Nutrigenomics Market by Product
9.3.5.4.2 Japan Nutrigenomics Market by Application
9.3.5.5 South Korea Nutrigenomics Market
9.3.5.5.1 South Korea Nutrigenomics Market by Product
9.3.5.5.2 South Korea Nutrigenomics Market by Application
9.3.5.6 Rest of Asia-Pacific Nutrigenomics Market
9.3.5.6.1 Rest of Asia-Pacific Nutrigenomics Market by Product
9.3.5.6.2 Rest of Asia-Pacific Nutrigenomics Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Nutrigenomics Market Overview
9.4.2 Middle East and Africa Nutrigenomics Market Forecasts and Analysis
9.4.3 Middle East and Africa Nutrigenomics Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Nutrigenomics Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Nutrigenomics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Nutrigenomics Market
9.4.5.1.1 South Africa Nutrigenomics Market by Product
9.4.5.1.2 South Africa Nutrigenomics Market by Application
9.4.5.2 Saudi Arabia Nutrigenomics Market
9.4.5.2.1 Saudi Arabia Nutrigenomics Market by Product
9.4.5.2.2 Saudi Arabia Nutrigenomics Market by Application
9.4.5.3 U.A.E Nutrigenomics Market
9.4.5.3.1 U.A.E Nutrigenomics Market by Product
9.4.5.3.2 U.A.E Nutrigenomics Market by Application
9.4.5.4 Rest of Middle East and Africa Nutrigenomics Market
9.4.5.4.1 Rest of Middle East and Africa Nutrigenomics Market by Product
9.4.5.4.2 Rest of Middle East and Africa Nutrigenomics Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Nutrigenomics Market Overview
9.5.2 South and Central America Nutrigenomics Market Forecasts and Analysis
9.5.3 South and Central America Nutrigenomics Market Forecasts and Analysis - By Product
9.5.4 South and Central America Nutrigenomics Market Forecasts and Analysis - By Application
9.5.5 South and Central America Nutrigenomics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Nutrigenomics Market
9.5.5.1.1 Brazil Nutrigenomics Market by Product
9.5.5.1.2 Brazil Nutrigenomics Market by Application
9.5.5.2 Argentina Nutrigenomics Market
9.5.5.2.1 Argentina Nutrigenomics Market by Product
9.5.5.2.2 Argentina Nutrigenomics Market by Application
9.5.5.3 Rest of South and Central America Nutrigenomics Market
9.5.5.3.1 Rest of South and Central America Nutrigenomics Market by Product
9.5.5.3.2 Rest of South and Central America Nutrigenomics Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NUTRIGENOMICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NUTRIGENOMICS MARKET, KEY COMPANY PROFILES
12.1. GX SCIENCES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CURA INTEGRATIVE MEDICINE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. HOLISTIC HEAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. INTERLEUKIN GENETICS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NUTRAGENE
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. METAGENICS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PATHWAY GENOMICS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GENE BOX
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NUTRIGENOMIX
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. XCODE LIFE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. WellGen Inc.
2. Metagenics, Inc.
3. Genomix Nutrition, Inc.
4. Nutrigenomix
5. NutraGene
6. XCODE Life Sciences Pvt. Ltd.
7. Cura Integrative Medicine
8. GX SCIENCES
9. Royal DSM
10. BASF SE
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Nutrigenomics Market
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Apr 2024